Darmstadt, Germany, February 28, 2014 – At its meeting today, the Supervisory Board of Merck KGaA, Darmstadt, Germany, nominated the candidates for the six shareholder representatives to be elected by the Annual General Meeting. In addition, the Supervisory Board also resolved to propose to the Annual General Meeting a 20 euro cent dividend increase to € 1.90 per share, as recommended by the Executive Board of Merck KGaA, Darmstadt, Germany.
The terms of office will expire for 16 members of the Supervisory Board of Merck KGaA, Darmstadt, Germany, upon the conclusion of the Annual General Meeting on May 9, 2014. The following persons are being proposed as candidates to represent the shareholders on the Supervisory Board being newly formed:
Wolfgang Büchele (54), CEO of Kemira Oyj and designated CEO of Linde AG, member of the Supervisory Board of Merck KGaA, Darmstadt, Germany, since July 1, 2009.
Michaela Freifrau von Glenck (67), teacher, member of the Supervisory Board of Merck KGaA, Darmstadt, Germany, since March 28, 2008.
Albrecht Merck (64), Commercial Director of the Castel Peter Winery, member of the Merck KGaA, Darmstadt, Germany, Supervisory Board since January 1, 2005.
Helga Rübsamen-Schaeff (65), Managing Director of AiCuris GmbH & Co. KG.
Gregor Schulz (63), Chairman of the Board of Biotest AG.
Theo Siegert (66), Managing Partner of de Haen Carstanjen & Söhne, member of the Supervisory Board of Merck KGaA, Darmstadt, Germany, since June 30, 2006.
Siegfried Karjetta (59) and Tobias Thelen (38) have been appointed to the Supervisory Board of Merck KGaA, Darmstadt, Germany, by E. Merck Beteiligungen KG, Darmstadt, Germany, as representatives of the Merck family of owners. With the exception of Michaela Freifrau von Glenck, the candidates are also members of the Board of Partners of E. Merck KG, Darmstadt, Germany.
If Wolfgang Büchele is elected to the Supervisory Board, the Board will propose that he be appointed chairman. The Supervisory Board consists of eight shareholder representatives and eight employee representatives, who are also to be newly appointed. The corresponding elections should be completed by the beginning of April. All candidates are to be elected or appointed for a term of five years to terminate at the 2019 Annual General Meeting.
Rolf Krebs, who has been a member of the Supervisory Board of Merck KGaA, Darmstadt, Germany, since June 30, 2006 and its chairman since July 23, 2009, has decided not to run for re-election and will instead resign from the Supervisory Board at the end of the 2014 Annual General Meeting. Three other Supervisory Board members have also decided not to run for re-election: Johannes Baillou, Frank Binder and Hans-Jürgen Leuchs.